View Financial HealthNorofert 배당 및 자사주 매입배당 기준 점검 0/6Norofert 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 19+ 2 more updatesNorofert S.A. to Report Q3, 2026 Results on Dec 03, 2026Norofert S.A. announced that they will report Q3, 2026 results on Dec 03, 2026공시 • Mar 24Norofert S.A., Annual General Meeting, Apr 29, 2026Norofert S.A., Annual General Meeting, Apr 29, 2026.공시 • Feb 25Norofert S.A. (BVB:NRF) agreed to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026.Norofert S.A. (BVB:NRF) entered into an agreement to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026. The transaction amounted to €0.1 million. The full amount will be paid by December 2026.분석 기사 • Jan 17Norofert S.A.'s (BVB:NRF) Business Is Trailing The Industry But Its Shares Aren'tWith a median price-to-sales (or "P/S") ratio of close to 1.4x in the Chemicals industry in Romania, you could be...분석 기사 • Dec 03Some Investors May Be Worried About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...Reported Earnings • Nov 27Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses.Reported Earnings • Sep 26Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024).Valuation Update With 7 Day Price Move • Jul 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to RON3.94, the stock trades at a trailing P/E ratio of 8x. Average trailing P/E is 21x in the Chemicals industry in Europe. Negligible returns to shareholders over past year.분석 기사 • Jul 15Here's Why Norofert (BVB:NRF) Has A Meaningful Debt BurdenDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • May 29First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses.분석 기사 • May 24Optimistic Investors Push Norofert S.A. (BVB:NRF) Shares Up 28% But Growth Is LackingNorofert S.A. ( BVB:NRF ) shareholders have had their patience rewarded with a 28% share price jump in the last month...Valuation Update With 7 Day Price Move • May 23Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON3.69, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 13% over the past year.분석 기사 • May 17There Are Reasons To Feel Uneasy About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...New Risk • May 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RON45.4m (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Market cap is less than US$10m (RON45.4m market cap, or US$9.98m).New Risk • Apr 23New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).New Risk • Apr 22New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 0% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).Reported Earnings • Apr 14Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023)Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.분석 기사 • Apr 01Norofert S.A.'s (BVB:NRF) Price In Tune With RevenuesIt's not a stretch to say that Norofert S.A.'s ( BVB:NRF ) price-to-sales (or "P/S") ratio of 1.2x seems quite...공시 • Mar 31Norofert S.A., Annual General Meeting, May 05, 2025Norofert S.A., Annual General Meeting, May 05, 2025.Reported Earnings • Dec 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: RON15.3m (up 11% from 3Q 2023). Net loss: RON473.8k (loss narrowed 76% from 3Q 2023).Reported Earnings • Oct 03Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: RON11.2m (up 30% from 2Q 2023). Net income: RON1.85m (up 29% from 2Q 2023). Profit margin: 17% (in line with 2Q 2023).분석 기사 • Sep 19Is Norofert (BVB:NRF) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Reported Earnings • Jun 04First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: RON11.7m (down 14% from 1Q 2023). Net income: RON1.4k (down 100% from 1Q 2023). Profit margin: 0% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue.Board Change • May 02No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Non-Executive Director Marian Alexe was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 NRF 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: NRF 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Norofert 배당 수익률 vs 시장NRF의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (NRF)n/a시장 하위 25% (RO)1.7%시장 상위 25% (RO)6.1%업계 평균 (Chemicals)3.3%분석가 예측 (NRF) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 NRF 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 NRF 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 NRF 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: NRF 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YRO 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 07:49종가2026/05/25 00:00수익2025/09/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Norofert S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 19+ 2 more updatesNorofert S.A. to Report Q3, 2026 Results on Dec 03, 2026Norofert S.A. announced that they will report Q3, 2026 results on Dec 03, 2026
공시 • Mar 24Norofert S.A., Annual General Meeting, Apr 29, 2026Norofert S.A., Annual General Meeting, Apr 29, 2026.
공시 • Feb 25Norofert S.A. (BVB:NRF) agreed to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026.Norofert S.A. (BVB:NRF) entered into an agreement to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026. The transaction amounted to €0.1 million. The full amount will be paid by December 2026.
분석 기사 • Jan 17Norofert S.A.'s (BVB:NRF) Business Is Trailing The Industry But Its Shares Aren'tWith a median price-to-sales (or "P/S") ratio of close to 1.4x in the Chemicals industry in Romania, you could be...
분석 기사 • Dec 03Some Investors May Be Worried About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Reported Earnings • Nov 27Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses.
Reported Earnings • Sep 26Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024).
Valuation Update With 7 Day Price Move • Jul 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to RON3.94, the stock trades at a trailing P/E ratio of 8x. Average trailing P/E is 21x in the Chemicals industry in Europe. Negligible returns to shareholders over past year.
분석 기사 • Jul 15Here's Why Norofert (BVB:NRF) Has A Meaningful Debt BurdenDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • May 29First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses.
분석 기사 • May 24Optimistic Investors Push Norofert S.A. (BVB:NRF) Shares Up 28% But Growth Is LackingNorofert S.A. ( BVB:NRF ) shareholders have had their patience rewarded with a 28% share price jump in the last month...
Valuation Update With 7 Day Price Move • May 23Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON3.69, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 13% over the past year.
분석 기사 • May 17There Are Reasons To Feel Uneasy About Norofert's (BVB:NRF) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
New Risk • May 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RON45.4m (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Market cap is less than US$10m (RON45.4m market cap, or US$9.98m).
New Risk • Apr 23New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).
New Risk • Apr 22New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 0% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m).
Reported Earnings • Apr 14Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023)Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.
분석 기사 • Apr 01Norofert S.A.'s (BVB:NRF) Price In Tune With RevenuesIt's not a stretch to say that Norofert S.A.'s ( BVB:NRF ) price-to-sales (or "P/S") ratio of 1.2x seems quite...
공시 • Mar 31Norofert S.A., Annual General Meeting, May 05, 2025Norofert S.A., Annual General Meeting, May 05, 2025.
Reported Earnings • Dec 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: RON15.3m (up 11% from 3Q 2023). Net loss: RON473.8k (loss narrowed 76% from 3Q 2023).
Reported Earnings • Oct 03Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: RON11.2m (up 30% from 2Q 2023). Net income: RON1.85m (up 29% from 2Q 2023). Profit margin: 17% (in line with 2Q 2023).
분석 기사 • Sep 19Is Norofert (BVB:NRF) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Reported Earnings • Jun 04First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: RON11.7m (down 14% from 1Q 2023). Net income: RON1.4k (down 100% from 1Q 2023). Profit margin: 0% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue.
Board Change • May 02No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Non-Executive Director Marian Alexe was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.